Join
Live feed
·
PRReleasevia Quantisnow
Voyager Therapeutics Inc. logo

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

ByQuantisnow·Wall Street's wire, on your screen.
VYGR· Voyager Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYGR (Voyager Therapeutics Inc.) and more on Quantisnow.